Agencia Española de Medicamentos y Productos Sanitarios (AEMPS)
CIMA — Centro de Información de Medicamentos · Spain
- Updated
- Not provided for this source record
- Synchronized
- Oct 2, 2026
Medicine · Spain
BARILUX 50 mg / ml CONCENTRADO PARA SUSPENSION ORAL Y RECTAL
Solution
Home Med Cabinet
Updated · Agencia Española de Medicamentos y Productos Sanitarios (AEMPS) — Not provided for this source record
Synchronized
At a glance
- Active ingredient
- BARIO SULFATO — 7.5 g
- Pharmaceutical form Home Med Cabinet grouping
- Solution
- Availability in Spain
- No packs currently marketed
Packs
BARILUX 50 mg / ml CONCENTRADO PARA SUSPENSION ORAL Y RECTAL, 20 frascos unidosis de 750 ml conteniendo 150 ml
National code
Not marketed603652Strength of this pack 50 mg
BARILUX 50 mg / ml CONCENTRADO PARA SUSPENSION ORAL Y RECTAL, 4 frascos multidosis de 2000 ml
8000 ml
National code
Not marketed603653Strength of this pack 50 mg
“Marketed” means the authority records the pack as placed on the market. It is not a statement about pharmacy stock.
Official documents
Documents open on the authority’s own site. Home Med Cabinet links to them and hosts no copy.
- Official
Opens on the authority’s own site
- Official
Summary of product characteristics
Opens on the authority’s own site
Registration
- Registration number
- 73287Official data
- Marketing authorisation holder
- IBEROINVESA PHARMA S.L.Official data
- Authorised
- Jan 17, 2011Official data
- Authority form code
- 1360Official data
Classification
ATC classification is not published here yet
Publication rights for ATC codes and labels are still under review, and no classification is inferred for this record.